Condensed Balance Sheets - USD ($)		Mar. 31, 2021	Dec. 31, 2020
Current assets:
Cash		$ 1,813,110
Prepaid expenses		874,176	$ 11,758
Total current assets		2,687,286	11,758
Deferred offering costs associated with proposed public offering			81,600
Investments held in Trust Account		250,000,869
Total Assets		252,688,155	93,358
Current liabilities:
Accounts payable		12,500
Accrued expenses		344,965	81,600
Total current liabilities		357,465	81,600
Derivative warrant liabilities		10,643,330
Deferred underwriting commissions		8,750,000
Total liabilities		19,750,795	81,600
Commitments and Contingencies
Shareholders' Equity:
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding as of March 31, 2021 and December 31, 2020
Additional paid-in capital		3,660,246	24,281
Retained earnings (accumulated deficit)		1,338,824	(13,242)
Total shareholders' equity		5,000,010	11,758
Total Liabilities and Shareholders' Equity		252,688,155	93,358
Common Class A [Member]
Current liabilities:
Class A ordinary shares, $0.0001 par value; 22,793,735 and -0- shares subject to possible redemption at $10.00 per share as of March 31, 2021 and December 31, 2020, respectively		227,937,350
Shareholders' Equity:
Common stock, value		221
Total shareholders' equity		221
Common Class B [Member]
Shareholders' Equity:
Common stock, value	[1]	719	719
Total shareholders' equity		$ 719	$ 719

[1] This number includes up to 937,500 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 4). On April 16, 2021, the underwriters partially exercised the over-allotment option to purchase an additional 3,342,178 Units. On April 18, 2021, the Sponsor forfeited 101,956 Class B ordinary shares.